These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2953168

  • 1. Yersinia arthritis, immune functions and histocompatibility antigens.
    Repo H, Leirisalo-Repo M, Gripenberg M, Koskimies S, Kontiainen S, Laitinen O.
    Acta Pathol Microbiol Immunol Scand C; 1986 Dec; 94(6):245-52. PubMed ID: 2953168
    [Abstract] [Full Text] [Related]

  • 2. Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro.
    Leirisalo M, Repo H, Tiilikainen A, Kosunen TU, Laitinen O.
    Arthritis Rheum; 1980 Sep; 23(9):1036-44. PubMed ID: 7417352
    [Abstract] [Full Text] [Related]

  • 3. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H, Leirisalo M, Tiilikainen A, Laitinen O.
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [Abstract] [Full Text] [Related]

  • 4. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H, Koivuranta-Vaara P, Leirisalo-Repo M.
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [Abstract] [Full Text] [Related]

  • 5. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P, Repo H, Leirisalo M, Kiistala U, Osterman T, Vapaatalo H.
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [Abstract] [Full Text] [Related]

  • 6. Antibody producing capacity to the bacteriophage phi X174 in yersinia arthritis.
    Bucknall R, Leirisalo-Repo M, Laitinen O, Jones JV.
    Ann Rheum Dis; 1987 Dec; 46(12):883-8. PubMed ID: 2962540
    [Abstract] [Full Text] [Related]

  • 7. Production of tumour necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis.
    Repo H, Jäättelä M, Leirisalo-Repo M, Hurme M.
    Clin Exp Immunol; 1988 Jun; 72(3):410-4. PubMed ID: 3262459
    [Abstract] [Full Text] [Related]

  • 8. Immune responses in yersinia-associated reactive arthritis.
    Aho K, Ahvonen P, Juvakoski T, Kousa M, Leirisalo M, Laitinen O.
    Ann Rheum Dis; 1979 Jun; 38 Suppl 1(Suppl 1):suppl 123-6. PubMed ID: 318096
    [No Abstract] [Full Text] [Related]

  • 9. Immune function in patients with previous yersinia arthritis: lymphocyte responses to PHA and Staphylococcus aureus strain Cowan I.
    Repo H, Leirisalo-Repo M.
    Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):39-43. PubMed ID: 3487200
    [Abstract] [Full Text] [Related]

  • 10. Yersinia antibodies in inflammatory joint diseases.
    Granfors K, Isomäki H, von Essen R, Maatela J, Kalliomäki JL, Toivanen A.
    Clin Exp Rheumatol; 1983 Feb; 1(3):215-8. PubMed ID: 6335856
    [Abstract] [Full Text] [Related]

  • 11. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R, Eskola J, Leino R, Koskimies S, Viander M.
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [Abstract] [Full Text] [Related]

  • 12. Yersinia arthritis: a clinical, immunological, and family study of 2 cases.
    Sheldon PJ, Mair NS, Fox E.
    Ann Rheum Dis; 1982 Apr; 41(2):153-8. PubMed ID: 6978685
    [Abstract] [Full Text] [Related]

  • 13. HLA phenotypes in patients with rheumatic fever, rheumatic heart disease, and Yersinia arthritis.
    Leirisalo M, Laitinen O, Tiilikainen A.
    J Rheumatol Suppl; 1977 Apr; 3():78-83. PubMed ID: 266605
    [Abstract] [Full Text] [Related]

  • 14. Effects of HLA-B27 positive and negative sera on migration of polymorphonuclear leukocytes in vitro.
    Repo H, Leirisalo-Repo M, Koskimies S.
    Clin Exp Rheumatol; 1988 Apr; 6(3):227-31. PubMed ID: 3263238
    [Abstract] [Full Text] [Related]

  • 15. Inflammation in Yersinia arthritis.
    Repo H, Meri S, Leirisalo-Repo M.
    Contrib Microbiol Immunol; 1987 Apr; 9():141-4. PubMed ID: 3499289
    [No Abstract] [Full Text] [Related]

  • 16. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects.
    Toivanen A, Granfors K, Lahesmaa-Rantala R, Leino R, Ståhlberg T, Vuento R.
    Immunol Rev; 1985 Aug; 86():47-70. PubMed ID: 3930389
    [Abstract] [Full Text] [Related]

  • 17. Complement activation and HLA-B27.
    Meri S, Partanen J, Leirisalo-Repo M, Repo H.
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [Abstract] [Full Text] [Related]

  • 18. Relation between HLA-B27 and clinical features in patients with yersinia arthritis.
    Laitinen O, Leirisalo M, Skylv G.
    Arthritis Rheum; 1977 Jun; 20(5):1121-4. PubMed ID: 869958
    [Abstract] [Full Text] [Related]

  • 19. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E, Umetsu D, Rosen F, Geha RS.
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [Abstract] [Full Text] [Related]

  • 20. Depressed lymphocyte transformation by yersinia and Escherichia coli in yersinia arthritis.
    Leino R, Vuento R, Koskimies S, Viander M, Toivanen A.
    Ann Rheum Dis; 1983 Apr; 42(2):176-81. PubMed ID: 6342552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.